Compare ADMA Biologics Inc (ADMA) vs Axogen Inc (AXGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Axogen Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Axogen Inc trades at $48.21 (market cap $2.61B). The key difference: Axogen Inc is the larger of the two by market cap, and Axogen Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | AXGN | |
|---|---|---|
Market Cap | $2.22B | $2.61B |
Sector | Health | Technology |
52-Week High | $20.38 | $48.48 |
52-Week Low | $7.60 | $14.16 |
Enterprise Value | $2.29B | $2.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →
